Binh An Phan
  • Assistant Professor
  • Cardiology
  • Public Health Sciences
Preventive Cardiology, Hyperlipidemia, Clinical Cardiology
Board Certifications
  • Cardiovascular Disease - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
Research Summary

Phan BA, Toth PP. Is The Future of Statins Aligned with New Lipid Modulation Therapies? Curr Atheroscler Rep. 2013 Feb;15(2):300-7.

Phan BA, Munoz L, Shadzi P, Isquith D, Triller M, Brown BG, Zhao XQ. Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (

Phan BA, Dayspring, TD, Toth PP. Ezetimibe therapy: mechanism of action and clinical update. Vasc Health Risk Manag. 2012;8:415-427.

Zhao QX, Li D, Hatsukami T, Phan BA, Chu B, Moore A, Lane T, Neradilek B, Polissar N, Monick D, Lee C, Underhill H, Yuan. C. Magnetic resonance imaging of plaque lipid depletion during lipid therapy: a prospective assessment of efficacy and time-course. JACC – Cardiovascular Imaging. 2011;4:977-86.

Moore A, Phan BA, Challender C, Williamson J, Marcovina S, Zhao XQ. Effects of adding extended release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease. J Clin Lipidology. 2007;1: 620-625.

Zhao XQ, Phan BA, Chu B, Bray F, Moore A, Dodge T, Lee C, Hatsukami T, Yuan C. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by MRI: study design of the Carotid Plaque Composition Study. Am Heart J. 2007;154:239-46.

Phan BA, Chu B, Polissar N, Hatsukami TS, Yuan C, Zhao XQ. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. Int J Cardiovasc Imaging. 2007;23:337-42.

Phan BA, Laflamme MA, Stempien-Otero A, Limaye, AP, Buckner FS, Levy WC. Confirmation of Chagas cardiomyopathy following heart transplantation. Heart Vessels. 2006;21:325-7.

Chu BC, Phan BA, Balui N, Yuan C, Brown BG, Zhao XQ. Reproducibility of carotid atherosclerotic lesion type characterization using high-resolution multicontrast weighted magnetic resonance imaging. J Cardiovasc Magn Reson. 2006;8:793-9

Phan BA, Chu BC, Kerwin WS, Xu D, Yuan C, Hatsukami T, Zhao XQ. Effect of contrast-enhancement on measurement of carotid arterial lumen and wall volume using MRI. J Magn Reson Imaging. 2006;23:481-5.


Dyslipidemia in women: etiology and managementPhan,B. A.; Toth,P. P.International journal of women's health 2014 ;6( ):185-194

Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment Study (HATS), Armed Forces Regression Study (AFREGS), and Carotid Plaque Composition by MRI during lipid-lowering (CPC) studyPhan,B. A.; Munoz,L.; Shadzi,P.; Isquith,D.; Triller,M.; Brown,B. G.; Zhao,X. Q.The American Journal of Cardiology 2013 ;111(3):352-355

Is the future of statins aligned with new novel lipid modulation therapies?Phan,B. A.; Toth,P. P.Current atherosclerosis reports 2013 ;15(2):300-012-0300-x

Ezetimibe therapy: mechanism of action and clinical updatePhan,B. A.; Dayspring,T. D.; Toth,P. P.Vascular Health & Risk Management 2012 ;8( ):415-427

Medical School
  • University of Michigan Medical School
  • University of Washington Medical Center, Internal Medicine: General
  • University of Washington Medical Center, Cardiology

After obtaining his medical degree with honors from the University of Michigan Medical School, he went on to complete his internal medicine residency and clinical cardiology fellowship training at the University of Washington Hospitals in Seattle, Washington. In addition to his clinical cardiology training, he completed a post-doctoral research fellowship at the University of Washington focused in the areas of advanced cholesterol management, non-invasive vascular imaging, and clinical trials.
Currently, he is an Assistant Professor of Medicine at Loyola University Chicago Stritch School of Medicine and an attending physician in the Division of Cardiology at Loyola University Medical Center. He serves as the Director of Loyola's Preventive Cardiology and Lipid Program and is the Associate Director of Cardiac Rehabilitation. His current research interests include evaluating the use of non-invasive atherosclerosis imaging to study the vascular effects of combination cholesterol therapies. His clinical interests are in preventive cardiology and lipidology. He is board certified by the American Board of Clinical Lipidology and is a Fellow of the American College of Cardiology. He currently is a member of the Board of Directors of the Midwest Lipid Association.

  • Vietnamese
  • Running